- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SYHA136 35 mg
Total 10392 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Classic Hodgkin LymphomaUnited States
-
Northwestern UniversitySeagen Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell... and other conditionsUnited States
-
Sinovac Biotech Co., LtdCompleted
-
Andros Day Surgery ClinicCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
University of WashingtonRecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedEverolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
University of Split, School of MedicineClinical Hospital Centre ZagrebUnknownApnea | Obesity | Respiratory Insufficiency | Sedation Complication | Hypoxic Respiratory Failure | Airway Obstruction, NasalCroatia
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.; Hôpitaux Universitaires Henri Mondor, FranceCompletedHodgkin's LymphomaUnited States
-
Klinikum ArnsbergRecruitingPeripheral Arterial DiseaseGermany
-
Joseph TuscanoNational Cancer Institute (NCI); Seagen Inc.RecruitingBrentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular LymphomaRecurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
University of Nove de JulhoCompletedTooth Discoloration
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin LymphomaUnited States
-
Lotus Clinical Research, LLCiX Biopharma Ltd.Completed
-
Pierre Fabre MedicamentCompleted
-
Medical College of WisconsinRecruitingHead and Neck CancerUnited States
-
Dr. Patrick CheungWithdrawnHormone Sensitive Oligometastatic Prostate CancerCanada
-
Universidade Federal de Santa MariaUnknown
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Refractory Childhood Hodgkin Lymphoma | Recurrent Childhood Hodgkin LymphomaUnited States, Canada
-
Alkahest, Inc.CompletedEnd-Stage Renal DiseaseUnited States
-
Beni-Suef UniversityCairo UniversityRecruitingAKI - Acute Kidney InjuryEgypt
-
Nabil AdraTerminatedNonseminomatous Germ Cell Tumor | Testis Cancer | Testicular Cancer | Embryonal Carcinoma | Germ Cell TumorsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
M.D. Anderson Cancer CenterTerminated
-
University of ChileCompleted
-
Universidade Federal do ParaCompletedColor | Bleaching SensitivityBrazil
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals...CompletedGerm Cell CancerItaly
-
Cairo UniversityNot yet recruiting
-
Lithuanian University of Health SciencesCompleted
-
Seagen Inc.Millennium Pharmaceuticals, Inc.No longer availableLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Cutaneous | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, United Kingdom, Belgium, Serbia, Australia, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, Switzerland
-
University of Kansas Medical CenterSeagen Inc.Recruiting
-
Texas Cardiac Arrhythmia Research FoundationRecruitingLeft Atrial Appendage Incomplete ClosureUnited States
-
Indonesia UniversityPT Paragon Technology and InnovationCompleted
-
Emory UniversityNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Boston Scientific CorporationWithdrawnChronic Venous Disorder | Venous Outflow Obstruction | Systemic Vein Outflow of Iliofemoral Vein
-
Sahlgrenska University Hospital, SwedenCompletedQuality of Life | Diabetic Foot | NeuropathySweden
-
Fondazione Italiana Linfomi ONLUSCompletedRelapsed/Refractory Hodgkin's LymphomaItaly
-
Seagen Inc.CompletedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin LymphomaPoland, Spain, Malaysia, Turkey, Germany, Czechia, Thailand
-
Fondazione Italiana Linfomi ONLUSCompletedPrimary Mediastinal Large B Cell LymphomaItaly
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, Germany
-
University of AlbertaRecruitingInsulin Resistance | Obesity, ChildhoodCanada
-
The Lymphoma Academic Research OrganisationCompletedHIV Infection | Stage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | HIV-associated Hodgkin LymphomaFrance
-
Cook Research IncorporatedCompleted
-
Grünenthal GmbHCompleted
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedDisease, HodgkinUnited States, France, Canada, Belgium, Italy
-
University of Alabama at BirminghamTerminated
-
Youn KimSeagen Inc.CompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma (CTCL) | Cutaneous Lymphoma | Non-Hodgkin Lymphoma (NHL)United States
-
Fundació Institut de Recerca de l'Hospital de la...Fundacion Clinic per a la Recerca BiomédicaRecruitingPreeclampsia | Intrauterine Growth Restriction | Perinatal Death | Maternal Hypertension | Neonatal OutcomeSpain, Belgium, Czechia, Poland, India